AFFINITY ASSET ADVISORS, LLC CRISPR Therapeutics AG Transaction History

AFFINITY ASSET ADVISORS, LLC portfolio value:

$0
portfolio value

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 call Decrease -100.00% -70K shares -4.25M $65.35 0
Q2 2022 call Increase +27.27% 15K shares 802K $60.77 70K
Q1 2022 call Increase 0.00% 55K shares 3.45M $62.77 55K
Q1 2021 share Decrease -100.00% -3.5K shares -536K $121.85 0
Q4 2020 share Increase 0.00% 3.5K shares 536K $153.11 3.5K